(ALISO VIEJO, Calif.)Valeant Pharmaceuticals International said Friday it bought Australia-based DermaTech Pty Ltd. for 19 million Australian dollars ($12.2 million) in a move to expand its dermatology...READ MORE

(ALISO VIEJO, Calif.)Valeant Pharmaceuticals International said Thursday it turned a profit in the third quarter after selling its businesses in western and eastern Europe, Africa and the Middle East.READ MORE

(ALISO VIEJO, Calif.)Valeant Pharmaceuticals International said Friday that British drugmaker GlaxoSmithKline PLC will market Valeant's epilepsy drug Diastat AcuDial in the U.S.READ MORE

(ALISO VIEJO, Calif.)Valeant Pharmaceuticals International said Friday it received an upfront payment of $125 million for a collaboration with GlaxoSmithKline to develop a new epilepsy treatment.READ MORE

(ALISO VIEJO, Calif.)Valeant Pharmaceuticals Inc. said Wednesday it will buy privately held Coria Laboratories Ltd. for $95 million in a move to expand its dermatology business.READ MORE

(ALISO VIEJO, Calif.)Drug maker Valeant Pharmaceuticals Inc. said Friday it completed the sale of its Eastern and Western European businesses to Meda AB of Sweden. Valeant agreed to sell most of its op...READ MORE

(ALISO VIEJO, Calif.)Valeant Pharmaceuticals International said Thursday it will collaborate with GlaxoSmithKline PLC to develop and market epilepsy drug candidates in a deal that could bring Valeant p...READ MORE